1. Home
  2. Medical Devices & Consumables
  3. Global Market Analysis Of End Stage Renal Disease Market By Treatment, By End User, And By Region (Global Market Forecast To 2027)

Global Market Analysis Of End Stage Renal Disease Market By Treatment, By End User, And By Region (Global Market Forecast To 2027)

Publication Month: Jun 2020 | No. of Pages: 128 Published By: Reports Intellect
Single User License: US $ 3500
Corporate User License: US $ 6500

Market Definition

The Global End Stage Renal Disease market is estimated at $ 65 billion in 2019, and expected to reach $ 172.80 billion by 2027, with a CAGR of 13% from 2020 to 2027.

End stage renal disease is a state in which chronic kidney disease reaches an advances state, where kidneys are not able to work normally.

Market Dynamics

The Global End Stage Renal Disease market is primarily driven by factors such as the growing occurrences of kidney diseases and kidney failure; technological innovation in the kidney related products; growing geriatric population; growing occurrences of diabetes, hypertension and other diseases having renal complication; growing focus on research and developments; are some of the market dynamics.

Market Segmentation

The Global End Stage Renal Disease Market is mainly classified based on Treatment, End User, and Region.

  • Based on Treatment, the market is further segmented into Renal Dialysis (Hemodialysis, Peritoneal Dialysis, Wearable Artificial Kidney) and Renal Transplantation
  • Based on End User, the market is further segmented into Dialysis Centers, Research and Academic Institutes, Hospitals & Clinics, and Other Users

Regional Analysis

Based on geography, the Global End Stage Renal Disease market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided into the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa                                                                                       

Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Competitive Landscape                     

Global End Stage Renal Disease Market, competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Global End Stage Renal Disease sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2019-2027, this study provides the Global End Stage Renal Disease sales, revenue and market share for each player covered in this report.

                                                                                  

The major players covered in Global End Stage Renal Disease are Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Medtronic Plc, Fresenius Medical Care AG & Co., Baxter International Inc., JMS Co. Ltd., Becton (Dickinson and Company), Nikkiso Co. Ltd., Cantel Medical, and other prominent players.

End Stage Renal Disease Market Key Segments:

By Treatment

  • Renal Dialysis
    • Hemodialysis
    • Peritoneal Dialysis
    • Wearable Artificial Kidney
  • Renal Transplantation

By End User

  • Hospitals & Clinics
  • Dialysis Centers
  • Research and Academic Institutes
  • Other Users

By Region             

  • North America
  • The U.S.A
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • GCC Countries
  • Egypt
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1 Market Overview

1.1 End Stage Renal Disease Introduction

1.2 Market Analysis by Treatment

1.2.1 Overview: Global End Stage Renal Disease Revenue by Treatment: 2019 VS 2021 VS 2027

1.2.2 Renal Dialysis

1.2.2.1 Hemodialysis

1.2.2.2 Peritoneal Dialysis

1.2.2.3 Wearable Artificial Kidney

1.2.3 Renal Transplantation

1.3 Market Analysis by End User

1.3.1 Overview: Global End Stage Renal Disease Revenue by End User: 2019 VS 2021 VS 2027

1.3.2 Hospitals & Clinics

1.3.3 Dialysis Centers

1.3.4 Research and Academic Institutes

1.3.5 Other Users

1.4 Overview of Global End Stage Renal Disease Market

1.4.1 Global End Stage Renal Disease Market Status and Outlook (2019-2027)

1.4.2 North America (United States, Canada and Mexico)

1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk 1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Medtronic Plc

2.1.1 Medtronic Plc Details

2.1.2 Medtronic Plc Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Medtronic Plc SWOT Analysis

2.1.4 Medtronic Plc Product and Services

2.1.5 Medtronic Plc End Stage Renal Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.2 Asahi Kasei Medical Co. Ltd.

2.2.1 Asahi Kasei Medical Co. Ltd. Details

2.2.2 Asahi Kasei Medical Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Asahi Kasei Medical Co. Ltd. SWOT Analysis

2.2.4 Asahi Kasei Medical Co. Ltd. Product and Services

2.2.5 Asahi Kasei Medical Co. Ltd. End Stage Renal Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.3 B. Braun Melsungen AG

2.3.1 B. Braun Melsungen AG Details

2.3.2 B. Braun Melsungen AG Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 B. Braun Melsungen AG SWOT Analysis

2.3.4 B. Braun Melsungen AG Product and Services

2.3.5 B. Braun Melsungen AG End Stage Renal Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.4 Fresenius Medical Care AG & Co.

2.4.1 Fresenius Medical Care AG & Co. Details

2.4.2 Fresenius Medical Care AG & Co. Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Fresenius Medical Care AG & Co. SWOT Analysis

2.4.4 Fresenius Medical Care AG & Co. Product and Services

2.4.5 Fresenius Medical Care AG & Co. End Stage Renal Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.5 Baxter International Inc.

2.5.1 Baxter International Inc. Details

2.5.2 Baxter International Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Baxter International Inc. SWOT Analysis

2.5.4 Baxter International Inc. on Product and Services

2.5.5 Baxter International Inc. End Stage Renal Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.6 JMS Co. Ltd.

2.6.1 JMS Co. Ltd. Details

2.6.2 JMS Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 JMS Co. Ltd. SWOT Analysis

2.6.4 JMS Co. Ltd. Product and Services

2.6.5 JMS Co. Ltd. End Stage Renal Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.7 Becton (Dickinson and Company)

2.7.1 Becton (Dickinson and Company) Details

2.7.2 Becton (Dickinson and Company) Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Becton (Dickinson and Company) SWOT Analysis

2.7.4 Becton (Dickinson and Company) Product and Services

2.7.5 Becton (Dickinson and Company) End Stage Renal Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.8 Nikkiso Co. Ltd.

2.8.1 Nikkiso Co. Ltd. Details

2.8.2 Nikkiso Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Nikkiso Co. Ltd. SWOT Analysis

2.8.4 Nikkiso Co. Ltd. Product and Services

2.8.5 Nikkiso Co. Ltd. End Stage Renal Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.9 Cantel Medical

2.9.1 Cantel Medical Details

2.9.2 Cantel Medical Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Cantel Medical SWOT Analysis

2.9.4 Cantel Medical Product & Services

2.9.5 Cantel Medical End Stage Renal Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2020) 2.10 Other Players

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global End Stage Renal Disease Sales and Market Share by Manufacturer (2019-2020)

3.2 Global End Stage Renal Disease Revenue and Market Share by Manufacturer (2019-2020)

3.3 Market Concentration Rate

3.3.1 Top 3 End Stage Renal Disease Manufacturer Market Share in 2019 & 2020

3.3.2 Top 6 End Stage Renal Disease Manufacturer Market Share in 2019 & 2020

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global End Stage Renal Disease Sales, Revenue and Market Share by Regions

4.1.1 Global End Stage Renal Disease Sales and Market Share by Regions (2019-2020)

4.1.2 Global End Stage Renal Disease Revenue and Market Share by Regions (2019-2020)

4.2 North America End Stage Renal Disease Sales and Growth Rate (2019-2020)

4.3 Europe End Stage Renal Disease Sales and Growth Rate (2019-2020)

4.4 Asia-Pacific End Stage Renal Disease Sales and Growth Rate (2019-2020)

4.5 South America End Stage Renal Disease Sales and Growth Rate (2019-2020)

4.6 Middle East and Africa End Stage Renal Disease Sales and Growth Rate (2019-2020)

5 North America by Country

5.1 North America End Stage Renal Disease Sales, Revenue and Market Share by Country

5.1.1 North America End Stage Renal Disease Sales and Market Share by Country (2019-2020)

5.1.2 North America End Stage Renal Disease Revenue and Market Share by Country (2019-2020)

5.2 United States End Stage Renal Disease Sales and Growth Rate (2019-2020)

5.3 Canada End Stage Renal Disease Sales and Growth Rate (2019-2020)

5.4 Mexico End Stage Renal Disease Sales and Growth Rate (2019-2020)

6 Europe by Country

6.1 Europe End Stage Renal Disease Sales, Revenue and Market Share by Country

6.1.1 Europe End Stage Renal Disease Sales and Market Share by Country (2019-2020)

6.1.2 Europe End Stage Renal Disease Revenue and Market Share by Country (2019-2020)

6.2 Germany End Stage Renal Disease Sales and Growth Rate (2019-2020)

6.3 UK End Stage Renal Disease Sales and Growth Rate (2019-2020)

6.4 France End Stage Renal Disease Sales and Growth Rate (2019-2020)

6.5 Russia End Stage Renal Disease Sales and Growth Rate (2019-2020)

6.6 Italy End Stage Renal Disease Sales and Growth Rate (2019-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific End Stage Renal Disease Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific End Stage Renal Disease Sales and Market Share by Regions (2019-2020)

7.1.2 Asia-Pacific End Stage Renal Disease Revenue and Market Share by Regions (2019-2020)

7.2 China End Stage Renal Disease Sales and Growth Rate (2019-2020)

7.3 Japan End Stage Renal Disease Sales and Growth Rate (2019-2020)

7.4 Korea End Stage Renal Disease Sales and Growth Rate (2019-2020)

7.5 India End Stage Renal Disease Sales and Growth Rate (2019-2020)

7.6 Southeast Asia End Stage Renal Disease Sales and Growth Rate (2019-2020)

7.7 Australia End Stage Renal Disease Sales and Growth Rate (2019-2020)

8 South America by Country

8.1 South America End Stage Renal Disease Sales, Revenue and Market Share by Country

8.1.1 South America End Stage Renal Disease Sales and Market Share by Country (2019-2020)

8.1.2 South America End Stage Renal Disease Revenue and Market Share by Country (2019-2020)

8.2 Brazil End Stage Renal Disease Sales and Growth Rate (2019-2020)

8.3 Argentina End Stage Renal Disease Sales and Growth Rate (2019-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa End Stage Renal Disease Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa End Stage Renal Disease Sales and Market Share by Country (2019-2020)

9.1.2 Middle East & Africa End Stage Renal Disease Revenue and Market Share by Country (2019-2020)

9.2 Saudi Arabia End Stage Renal Disease Sales and Growth Rate (2019-2020)

9.3 Turkey End Stage Renal Disease Sales and Growth Rate (2019-2020)

9.4 Egypt End Stage Renal Disease Sales and Growth Rate (2019-2020)

9.5 South Africa End Stage Renal Disease Sales and Growth Rate (2019-2020)

10 Global End Stage Renal Disease Market Segment by Treatment

10.1 Global End Stage Renal Disease Sales Market Share by Treatment (2019-2020)

10.2 Global End Stage Renal Disease Revenue Market Share by Treatment (2019-2020)

10.3 Global End Stage Renal Disease Price by Treatment (2019-2020)

11 Global End Stage Renal Disease Market Segment by End User

11.1 Global End Stage Renal Disease Sales Market Share by End User (2019-2020)

11.2 Global End Stage Renal Disease Revenue Market Share by End User (2019-2020)

11.3 Global End Stage Renal Disease Price by End User (2019-2020)

12 Market Forecast

12.1 Global End Stage Renal Disease Sales, Revenue and Growth Rate (2021-2027)

12.2 End Stage Renal Disease Market Forecast by Regions (2021-2027)

12.2.1 North America End Stage Renal Disease Market Forecast (2021-2027)

12.2.2 Europe End Stage Renal Disease Market Forecast (2021-2027)

12.2.3 Asia-Pacific End Stage Renal Disease Market Forecast (2021-2027)

12.2.4 South America End Stage Renal Disease Market Forecast (2021-2027)

12.2.5 Middle East & Africa End Stage Renal Disease Market Forecast (2021-2027)

12.3 End Stage Renal Disease Market Forecast by Treatment (2021-2027)

12.3.1 Global End Stage Renal Disease Sales Forecast by Treatment (2021-2027)

12.3.2 Global End Stage Renal Disease Market Share Forecast by Treatment (2021-2027)

12.4 End Stage Renal Disease Market Forecast by End User (2021-2027)

12.4.1 Global End Stage Renal Disease Sales Forecast by End User (2021-2027)

12.4.2 Global End Stage Renal Disease Market Share Forecast by End User (2021-2027)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

15.3 Disclaimer

15.4 About Us

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets